Gameto is a biopharma, biotechnology and genetics company based in New York. Founded by Dina Radenkovic, Martin Varsavsky and Pranam Chatterjee, Gameto is on a mission to redefine female reproductive health. Gameto is making strides to produce female reproductive cell lines using cellular engineering, and they have developed a platform to advance a portfolio of cellular therapeutics for female reproductive diseases. Their first program, Fertilo, is looking to make IVF and egg freezing more effective and safer.
Treadwell Therapeutics is a biotechnology company based in New York, New York. The company develops medicines to address unmet needs in patients with cancer. They have a robust internally developed pipeline which includes a first-in-class PLK4 kinase inhibitor, CFI-400945 and a TTK inhibitor, CFI-402257.
Ozette Technologies, based in New York, New York, develops an artificial intelligence-enabled immune monitoring platform. Founded in 2020 by Raphael Gottardo, Greg Finak, Ali Ansary, and Evan Greene, their technology is used to quickly extract reliable insights from single-cell data across instruments and disease states.
Gennao Bio is a biotech firm based in New York, that is pioneering advancements in targeted nucleic acid therapeutics. Their proprietary gene monoclonal antibody (GMAB) platform technology is being developed with a focus on addressing significant unmet needs in oncology and rare monogenic skeletal muscle diseases.
76Bio, based in New York, New York, develops therapies for patients with life-threatening diseases. They are specializing in pioneering targeted protein degraders. Founded in 2020, 76Bio is committed to making strides in the field of biotechnology.
Reset Pharmaceuticals is a biotech company based in New York. They focus on the development and commercialization of novel psychedelic treatments for patients with life-threatening illnesses, including cancer.
Graviton, based in New York, develops novel therapeutics for the treatment of serious diseases such as autoimmune diseases, cancer, and genetic and fibrotic diseases. Their lead candidate, TDI01, a potent inhibitor of Rho/Rho-associated coiled-coil containing protein kinase 2 (ROCK2) is being studied for the treatment of idiopathic pulmonary fibrosis (IPF).
Nine Square Therapeutics
Nine Square Therapeutics, based in New York, is focused on discovering new small-molecule therapeutics for degenerative movement disorders. They integrate computational chemistry, biophysics, and computational biology into machine-learning-enabled cell profiling platforms for target identification, chemical optimization, and patient stratification.
Isabl Inc, based in New York, specializes in the field of whole-genome cancer diagnostics. The company is currently looking to partner with oncology centers nationwide to showcase the value of using whole-genome sequencing in clinical cancer care.
Digital Health and Discovery Platform (DHDP)
The Digital Health and Discovery Platform (DHDP), based in New York, aims to transform cancer research and care in Canada by enabling the new Marathon of Hope Cancer Centers network to analyze enormous amounts of genomic and clinical data to find new and better ways to treat cancer patients.
Aerwave Medical, based in New York, New York, develops an alternative to traditional medications used to treat COPD and asthma. Their interventional approach provides improvement for patients who are refractory to drug therapy.